Scarica l'app Stockscreener
20.85
4.77%
0.95
Dopo l'orario di chiusura:
20.85
Dianthus Therapeutics Inc Azioni (DNTH) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2024-03-31 | 2023-09-30 |
| Durata del periodo | 3 mesi | 3 mesi |
| Revenues |
5.41%
0.874
|
0.924 |
Operating Expenses
|
12.20%
18.72
|
16.68 |
| Benefits Costs and Expenses |
14.62
|
- |
| Costs And Expenses |
12.20%
18.72
|
16.68 |
| Operating Income/Loss |
13.23%
-17.84
|
-15.76 |
| Nonoperating Income/Loss |
311.24%
4.096
|
0.996 |
| Income/Loss From Continuing Operations Before Tax |
1,588%
-13.75
|
0.924 |
| Income/Loss From Continuing Operations After Tax |
6.88%
-13.75
|
-14.76 |
|
Net Income/Loss
|
6.88%
-13.75
|
-14.76 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- |
| Attributable To Noncontrolling Interest |
-
|
- |
| Basic Average Shares |
556.93%
25.67
|
3.9069 |
| Diluted Average Shares |
556.93%
25.67
|
3.9069 |
| Basic Earnings Per Share |
85.71%
-0.54
|
-3.78 |
| Diluted Earnings Per Share |
85.71%
-0.54
|
-3.78 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- |
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):